Immunotherapy Today

Immunotherapy News From Around The World

< Immunotherapy Today home

Author: btwatson

  • Is Immunotherapy the Key to Developing an HIV Vaccine? – AJMC.com Managed Markets Network
    Is Immunotherapy the Key to Developing an HIV Vaccine? – AJMC.com Managed Markets Network
  • The State of Immunotherapy in Bladder Cancer – Thomas Powles – UroToday
    The State of Immunotherapy in Bladder Cancer – Thomas Powles – UroToday
  • The State of Immunotherapy in Bladder Cancer – Thomas Powles – UroToday
    The State of Immunotherapy in Bladder Cancer – Thomas Powles – UroToday
  • Colon Cancer Changes Its Spots to Dodge Latest Immunotherapies – Genetic Engineering & Biotechnology News
    Colon Cancer Changes Its Spots to Dodge Latest Immunotherapies – Genetic Engineering & Biotechnology News
  • Gilead-partnered Vienna-based immunotherapy company Hookipa makes Nasdaq debut with downsized $84M IPO – Endpoints News
    Gilead-partnered Vienna-based immunotherapy company Hookipa makes Nasdaq debut with downsized $84M IPO – Endpoints News
  • Inovio’s Phase 3 HPV Immunotherapy Selected As “Best Therapeutic Vaccine” at World Vaccine Congress – PRNewswire
  • The Gut Microbiome & Cancer Immunotherapy : Oncology Times – LWW Journals
    The Gut Microbiome & Cancer Immunotherapy : Oncology Times – LWW Journals
  • Dr. Fakih on Immunotherapy in MSS Colon Cancer – OncLive
    Dr. Fakih on Immunotherapy in MSS Colon Cancer – OncLive
  • Two Patients Treated with CRISPRed Cells in Immunotherapy Trial – The Scientist
    Two Patients Treated with CRISPRed Cells in Immunotherapy Trial – The Scientist
  • Dr. Socinski on New Applications of Immunotherapy in NSCLC – OncLive
    Dr. Socinski on New Applications of Immunotherapy in NSCLC – OncLive
< Newer Entries   |   Older Entries >
Copyright 2018 ImmunoTherapyToday.com